Icad Inc Revenue Growth Rates (ICAD), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Icad Inc  (NASDAQ: ICAD)
 

ICAD's Revenue Growth by Quarter and Year

Icad Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ICAD Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 4.87
FY 4.87

ICADs Annual Revenue
Icad Inc's Revenue in the fiscal year 2024 $ 18.64 millions
Icad Inc's Revenue in the fiscal year 2023 $ 16.79 millions
Icad Inc's Revenue in the fiscal year 2022 $ 27.94 millions
Icad Inc's Revenue in the fiscal year 2021 $ 33.64 millions
Icad Inc's Revenue in the fiscal year 2020 $ 30.08 millions




ICAD Revenue first quarter 2025 Y/Y Growth Comment
Icad Inc reported decrease in Revenue in the first quarter 2025 by -1.54% to $ 4.87 millions, from the same quarter in 2024.
The decrease in the first quarter 2025 Icad Inc's Revenue compares unfavorably to the Company's average Revenue growth of 1.5%.

Looking into first quarter 2025 results within Medical Equipment & Supplies industry 120 other companies have achieved higher Revenue growth. While Icad Inc' s Revenue decline of -1.54% ranks overall at the positon no. 2427 in the first quarter 2025.


ICAD Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter December - 179.25 % -75.5 % -14.27 %
3rd Quarter September - 3.69 % -36.01 % -32.63 %
2nd Quarter June - -5.98 % -29.42 % -4.17 %
1st Quarter March -1.54 % -14.36 % -23.14 % -13.76 %
FY   - 11.02 % -39.93 % -

Financial Statements
Icad Inc's first quarter 2025 Revenue $ 4.87 millions ICAD's Income Statement
Icad Inc's first quarter 2024 Revenue $ 4.95 millions Quarterly ICAD's Income Statement


ICAD Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter December - 5.21 % -60.93 % 2.04 %
3rd Quarter September - -16.1 % -23.93 % -16.09 %
2nd Quarter June - 1.62 % -7.44 % 0.8 %
1st Quarter March 9.77 % 211.32 % -10.94 % -0.66 %
FY (Year on Year)   - 11.02 % -39.93 % -


Back to ICAD Growth rate Comparisons >> Back to ICAD Growth rate Comparisons >>


Revenue first quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #121
Healthcare Sector #373
Overall #2427

Revenue Y/Y Growth Statistics
High Average Low
179.81 % 1.5 % -75.58 %
(March 31, 2015)   (Sep 30 2016)
Revenue first quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #121
Healthcare Sector #373
Overall #2427
Revenue Y/Y Growth Statistics
High Average Low
179.81 % 1.5 % -75.58 %
(March 31, 2015)   (Sep 30 2016)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Icad Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
212.56 % 2.94 % -61.09 %
(Mar 31 2024)  


ICAD's I. Quarter Q/Q Revenue Comment
Icad Inc achieved in the I. Quarter 2025 above company average sequential Revenue increase of 9.77%, to $ 4.87 millions, from $4.44 millions in the fourth quarter.

Within Medical Equipment & Supplies industry 16 other companies have achieved higher Revenue quarter on quarter growth. While Icad Inc's Revenue growth quarter on quarter, overall rank is 573.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #17
Healthcare Sector #105
Overall #573
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #17
Healthcare Sector #105
Overall #573
Revenue Q/Q Growth Statistics
High Average Low
212.56 % 2.94 % -61.09 %
(Mar 31 2024)  


ICAD's I. Quarter Q/Q Revenue Comment
Icad Inc achieved in the I. Quarter 2025 above company average sequential Revenue increase of 9.77%, to $ 4.87 millions, from $4.44 millions in the fourth quarter.

Within Medical Equipment & Supplies industry 16 other companies have achieved higher Revenue quarter on quarter growth. While Icad Inc's Revenue growth quarter on quarter, overall rank is 573.


Icad Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2025)		 12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)
Cumulative Revenue 12 Months Ending $ 18.56 $ 18.63 $ 15.79 $ 15.64 $ 15.96
Y / Y Revenue Growth (TTM) 16.25 % 11.02 % -27.22 % -34.76 % -39.08 %
Year on Year Revenue Growth Overall Ranking # 3386 # 3138 # 2682 # 2351 # 2263
Seqeuential Revenue Change (TTM) -0.43 % 18.06 % 0.92 % -2 % -4.91 %
Seq. Revenue Growth (TTM) Overall Ranking # 2643 # 2992 # 2303 # 1944 # 1826


Cumulative Revenue growth Comment
Icad Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 16.25% year on year, to $ 19 millions if the fiscal year would have ended in Mar 31 2025.
Icad Inc's trailing twelve months Revenue growth was higher than company's average -4.04% and higher than 11.02% growth in Dec 31 2024.

In the Healthcare sector 470 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3138 to 3386.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 125
Healthcare Sector # 471
Overall # 3386

Revenue TTM Y/Y Growth Statistics
High Average Low
44.47 %
 -4.04 %
-42.65 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 125
Sector # 379
S&P 500 # 2643
Cumulative Revenue growth Comment
Icad Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 16.25% year on year, to $ 19 millions if the fiscal year would have ended in Mar 31 2025.
Icad Inc's trailing twelve months Revenue growth was higher than company's average -4.04% and higher than 11.02% growth in Dec 31 2024.

In the Healthcare sector 470 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3138 to 3386.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 125
Healthcare Sector # 471
Overall # 3386

Revenue TTM Y/Y Growth Statistics
High Average Low
44.47 %
-4.04 %
-42.65 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 125
Sector # 379
S&P 500 # 2643




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ICAD's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Mar 31 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2025
Carlisle Companies Incorporated-0.06%$ -0.064 millions
Henry Schein Inc -0.13%$ -0.126 millions
Tactile Systems Technology Inc -0.14%$ -0.137 millions
Alpha Pro Tech Ltd -0.19%$ -0.186 millions
Premier Air Charter Holdings Inc -0.20%$ -0.204 millions
Gilead Sciences Inc -0.28%$ -0.284 millions
Adm Tronics Unlimited Inc -0.32%$ -0.315 millions
Jazz Pharmaceuticals Plc-0.46%$ -0.459 millions
Milestone Scientific Inc -0.73%$ -0.730 millions
Logicmark Inc-0.74%$ -0.738 millions
Yunhong Green Cti Ltd -0.74%$ -0.745 millions
Amphastar Pharmaceuticals Inc -0.76%$ -0.761 millions
Enhabit Inc -0.95%$ -0.953 millions
Elanco Animal Health Incorporated-1.00%$ -0.996 millions
3m Company-1.03%$ -1.031 millions
Envista Holdings Corporation-1.17%$ -1.171 millions
Globus Medical Inc -1.41%$ -1.409 millions
Proqr Therapeutics N v -1.53%$ -1.528 millions
Merck and Co Inc -1.56%$ -1.559 millions
Icad Inc-1.61%$ -1.615 millions
Fortrea Holdings Inc -1.63%$ -1.631 millions
Align Technology inc -1.78%$ -1.776 millions
Adapthealth Corp -1.84%$ -1.844 millions
Sunlink Health Systems Inc -2.05%$ -2.050 millions
Tonix Pharmaceuticals Holding Corp -2.14%$ -2.135 millions
Alpha Teknova Inc -2.19%$ -2.194 millions
Quidelortho Corp-2.56%$ -2.560 millions
Teladoc Health Inc -2.59%$ -2.594 millions
Tenet Healthcare Corp-2.70%$ -2.701 millions
Charles River Laboratories International inc -2.71%$ -2.708 millions


About Icad Inc Revenue Growth Rates (ICAD), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Icad Inc (CIK 749660).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-25-016489
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Icad Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.